TY - JOUR
T1 - Maturation of the SARS-CoV-2 virus is regulated by dimerization of its main protease
AU - Kaptan, Shreyas
AU - Girych, Mykhailo
AU - Enkavi, Giray
AU - Kulig, Waldemar
AU - Sharma, Vivek
AU - Vuorio, Joni
AU - Rog, Tomasz
AU - Vattulainen, Ilpo Tapio
PY - 2022
Y1 - 2022
N2 - SARS-CoV-2 main protease (Mpro) involved in COVID-19 is required for maturation of the virus and infection of host cells. The key question is how to block the activity of Mpro. By combining atomistic simulations with machine learning, we found that the enzyme regulates its own activity by a collective allosteric mechanism that involves dimerization and binding of a single substrate. At the core of the collective mechanism is the coupling between the catalytic site residues, H41 and C145, which direct the activity of Mpro dimer, and two salt bridges formed between R4 and E290 at the dimer interface. If these salt bridges are mutated, the activity of Mpro is blocked. The results suggest that dimerization of main proteases is a general mechanism to foster coronavirus proliferation, and propose a robust drug-based strategy that does not depend on the frequently mutating spike proteins at the viral envelope used to develop vaccines.
AB - SARS-CoV-2 main protease (Mpro) involved in COVID-19 is required for maturation of the virus and infection of host cells. The key question is how to block the activity of Mpro. By combining atomistic simulations with machine learning, we found that the enzyme regulates its own activity by a collective allosteric mechanism that involves dimerization and binding of a single substrate. At the core of the collective mechanism is the coupling between the catalytic site residues, H41 and C145, which direct the activity of Mpro dimer, and two salt bridges formed between R4 and E290 at the dimer interface. If these salt bridges are mutated, the activity of Mpro is blocked. The results suggest that dimerization of main proteases is a general mechanism to foster coronavirus proliferation, and propose a robust drug-based strategy that does not depend on the frequently mutating spike proteins at the viral envelope used to develop vaccines.
KW - Biophysics
KW - Coronavirus
KW - Machine learning
KW - Molecular dynamics simulation
UR - http://www.scopus.com/inward/record.url?scp=85133239780&partnerID=8YFLogxK
U2 - 10.1016/j.csbj.2022.06.023
DO - 10.1016/j.csbj.2022.06.023
M3 - Article
C2 - 35720615
SN - 2001-0370
VL - 20
SP - 3336
EP - 3346
JO - Computational and Structural Biotechnology Journal
JF - Computational and Structural Biotechnology Journal
ER -